These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3757178)

  • 1. Conditional oncogenicity of perfused adriamycin in the tourniquet-isolated rat limb.
    Van't Hoff SC; van Dijk WJ; Buys WJ; Van der Valk MA; Benckhuijsen C
    Carcinogenesis; 1986 Oct; 7(10):1787-9. PubMed ID: 3757178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities.
    Klaase JM; Kroon BB; Benckhuijsen C; van Geel AN; Albus-Lutter CE; Wieberdink J
    Cancer; 1989 Aug; 64(3):616-21. PubMed ID: 2743257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
    Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
    Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of regional versus systemic chemotherapy with adriamycin.
    Didolkar MS; Kanter PM; Baffi RR; Schwartz HS; Lopez R
    Ann Surg; 1978 Mar; 187(3):332-6. PubMed ID: 637593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue toxicity in experimental isolated perfusion with adriamycin.
    Henneking K; Aigner K; Deeg C; Merker G; Spelz HW; Hundeiker M
    Recent Results Cancer Res; 1983; 86():254-9. PubMed ID: 6648006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
    Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
    In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Doxorubicin in antiblastic hyperthermic perfusion in the treatment of advanced soft-tissue sarcoma of the limbs].
    Di Filippo F; Patrizi V; Cavaliere F; Garinei R; Anzà M; Perri P; Botti C; Di Filippo S; Vespa A
    Suppl Tumori; 2005; 4(3):S126-7. PubMed ID: 16437946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of free and liposomal doxorubicin after isolated lung perfusion in a sarcoma model.
    Yan H; Cheng C; Haouala A; Krueger T; Ballini JP; Peters S; Decosterd LA; Letovanec I; Ris HB; Andrejevic-Blant S
    Ann Thorac Surg; 2008 Apr; 85(4):1225-32. PubMed ID: 18355500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma.
    Di Filippo F; Garinei R; Anzà M; Cavaliere F; Giannarelli D; Cagol PP; Rossi CR; Santinami M; Deraco M; Botti C; Perri P; Di Filippo S; Piarulli L; Bruno P
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):81-7. PubMed ID: 16767912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated single-lung perfusion: a study of the optimal perfusate and other pharmacokinetic factors.
    Weksler B; Ng B; Lenert JT; Burt ME
    Ann Thorac Surg; 1995 Sep; 60(3):624-9. PubMed ID: 7545890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-flow isolation perfusion of the rat hind limb in vivo.
    Benckhuysen C; Van Dijk WJ; Van't Hoff SC
    J Surg Oncol; 1982 Dec; 21(4):249-57. PubMed ID: 7144205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [O2 utilization during hyperthermic extremity perfusion with rhTNF alpha and melphalan].
    Haier J; Hohenberger P; Beck K; Schlag PM
    Langenbecks Arch Chir; 1997; 382(3):128-33. PubMed ID: 9324610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional chemotherapy via pulmonary artery with blood flow occlusion in a solitary tumor nodule model.
    Wang HY; Hochwald S; Ng B; Burt M
    Anticancer Res; 1996; 16(6B):3749-53. PubMed ID: 9042252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
    Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
    Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
    Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
    Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of exogenous coenzyme Q against damage by adriamycin in perfused rat liver.
    Valls V; Castelluccio C; Fato R; Genova ML; Bovina C; Saez G; Marchetti M; Parenti Castelli G; Lenaz G
    Biochem Mol Biol Int; 1994 Jul; 33(4):633-42. PubMed ID: 7981650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antitumour effect of TNF-SAM2 with melphalan and doxorubicin in isolated limb perfusion in rats.
    de Wilt JH; Soma G; ten Hagen TL; Kanou J; Takagi K; Nooijen PT; Seynhaevel AL; Eggermont AM
    Anticancer Res; 2000; 20(5B):3491-6. PubMed ID: 11131652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies.
    Smith HG; Wilkinson MJ; Smith MJF; Strauss DC; Hayes AJ
    Eur J Cancer; 2018 Sep; 100():46-54. PubMed ID: 29940423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and validation of a microprocessor controlled extracorporal circuit in rats for the optimization of isolated limb perfusion.
    Gürtler U; Fuchs P; Stangelmayer A; Bernhardt G; Buschauer A; Spruss T
    Arch Pharm (Weinheim); 2004 Dec; 337(12):672-81. PubMed ID: 15597400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.
    Rossi CR; Mocellin S; Pilati P; Foletto M; Campana L; Quintieri L; De Salvo GL; Lise M
    Ann Surg Oncol; 2005 May; 12(5):398-405. PubMed ID: 15915374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.